Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The tumor suppressor activity of SOCS-1.

Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P, de Sepulveda P.

Oncogene. 2002 Jun 27;21(28):4351-62.

2.
3.

The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.

Iwamoto T, Senga T, Naito Y, Matsuda S, Miyake Y, Yoshimura A, Hamaguchi M.

Oncogene. 2000 Sep 28;19(41):4795-801.

4.

v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells.

Limnander A, Danial NN, Rothman PB.

Mol Cell. 2004 Aug 13;15(3):329-41.

5.

The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2.

Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, Kitamura T, Kato H, Nakayama Ki, Yoshimura A.

J Biol Chem. 2001 Apr 20;276(16):12530-8.

6.

Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.

Flowers LO, Johnson HM, Mujtaba MG, Ellis MR, Haider SM, Subramaniam PS.

J Immunol. 2004 Jun 15;172(12):7510-8.

7.

The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.

Monni R, Santos SC, Mauchauffe M, Berger R, Ghysdael J, Gouilleux F, Gisselbrecht S, Bernard O, Penard-Lacronique V.

Oncogene. 2001 Feb 15;20(7):849-58.

9.

A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.

Qiu X, Guo G, Chen K, Kashiwada M, Druker BJ, Rothman PB, Chen JL.

Neoplasia. 2012 Jun;14(6):547-58.

10.

SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.

Tomic S, Chughtai N, Ali S.

Mol Cell Endocrinol. 1999 Dec 20;158(1-2):45-54.

PMID:
10630404
11.

Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.

Pezet A, Favre H, Kelly PA, Edery M.

J Biol Chem. 1999 Aug 27;274(35):24497-502.

12.

Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation.

Qing Y, Costa-Pereira AP, Watling D, Stark GR.

J Biol Chem. 2005 Jan 21;280(3):1849-53.

13.

Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase.

Peraldi P, Filloux C, Emanuelli B, Hilton DJ, Van Obberghen E.

J Biol Chem. 2001 Jul 6;276(27):24614-20.

14.

Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.

Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffé M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA.

Blood. 2000 Mar 15;95(6):2076-83.

15.

Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling.

Bayle J, Letard S, Frank R, Dubreuil P, De Sepulveda P.

J Biol Chem. 2004 Mar 26;279(13):12249-59.

16.

Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.

Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N.

Mol Endocrinol. 1999 Nov;13(11):1832-43.

PMID:
10551777
17.
18.

Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.

Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA.

EMBO J. 1999 Jan 15;18(2):375-85.

19.
20.

Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.

Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE, Arlinghaus RB.

Oncogene. 2001 Sep 27;20(43):6188-95.

Items per page

Supplemental Content

Support Center